Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinib
Section of Experimental Haematology, Division of Cancer Sciences and Molecular Pathology, Paul O'Gorman Leukaemia Research Centre, Gartnavel General Hospital, Faculty of Medicine, University of Glasgow, Glasgow, UK
Received 23 December 2008; received in revised form 23 December 2008; accepted 11 February 2009. published online 17 February 2009.
PII: S0301-472X(09)00054-X
doi:10.1016/j.exphem.2009.02.006
© 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.